Search inquiry: <.>II=ЕУ12/2017/39/1<.> |
Total number of found documents : 29
Shown documents from 1 till 20 |
|
>1.
| Circulating tumor cells in breast cancer/N. V. Cherdyntseva [et al.] // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.2-11
|
>2.
| Kashuba E. Do MRPS 18-2 and RB proteins cooperate to control cell stemness and differentiation, preventing cancer development?/E. Kashuba, M. Mushtag // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.12-16
|
>3.
| Effect of antitumor drugs in low concentrations on the biological, immunophenotypic and cytogenetic characteristics of human colon cancer cells in vitro/N. Bezdieniezhnych [et al.] // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.17-24
|
>4.
| Artemisinin modulating effect on human breast cancer cell lines with different sensitivity to cytostatics/V. F. Chekhun [et al.] // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.25-29
|
>5.
| Parthenolide reduces gene transcription of prosurvival mediators in U937 cells/S. Mohammadi [et al.] // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.30-35
|
>6.
| Anti-histone H1 IgGs prossess proliferative activity towards human T-leukemia CEM cells/Yu. Kit [et al.] // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.36-41
|
>7.
| Anticancer effect and immunologic response to xenogeneic embryonic proteins in mice bearing Ehrlich solid carcinoma/T. V. Symchych [et al.] // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.42-48
|
>8.
| EPR spectroscopy studies of changes in erythrocyte membranes in patients with laryngeal cancer/Y. B. Burlaka [et al.] // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.49-52
|
>9.
| Auzina D. Prognostic value of the bone turnover markers in multiple myeloma/D. Auzina, R. Erts, S. Lejniece // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.53-56
|
>10.
| Aberrant promoter hypermethylation of selected apoptotic genes in childhood acute lymphoblastic leukemia among North Indian population/M. Nikbakht [et al.] // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.57-64
|
>11.
| Chekhun V.F. Significance of iodine symporter for prognosis of the disease course and efficacy of neoadjuvant chemotherapy in patients with breast cancer of luminal and basal subtypes/V. F. Chekhun, A. V. Andriiv, N. Yu. Lukianova // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.65-68
|
>12.
| Satinder K. Impact of single nucleotide polymorphism in chemical metabolizing genes and exposure to wood smoke on risk of cervical cancer in North-Indian women/K. Satinder, R. C. Sobti, K. Pushpinder // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.69-74
|
>13.
| The impact of coloregional treatment on survival of patients with primary metastatic breast cancer/R. Liubota [et al.] // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.75-77
|
>14.
| Diagnostic challenges with intraoral myeloid sarcoma/P. Kumar [et al.] // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.78-85
|
>15.
| Trichilemmal cystis in metastatic melanoma/I. Savarese [et al.] // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.86-87
|
>16.
| Materials of international vactrain/ 3-rd Swedish-Ukrainian conference on cancer diseases, January 16-17, 2017, Stockholm, Sweden // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.88-93
|
>17.
| Endoplasmic reticulum stress as a key factor of genome reprogramming in cancer cells/O. O. Ratushna [et al.] // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.88-89
|
>18.
| The adaptor protein Ruk/CIN85 paradoxically enhances EMT of triple negative mouse breast adenocarcinoma 4T1 cells/I. Horak [et al.] // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.89
|
>19.
| Biological characteristics of tumor cells at the different stages of EMT upon exposure to anticancer drugs and cytokines/N. Bezdieniezhnych [et al.] // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.89-90
|
>20.
| Alternative direction of inhibition of malignant properties in tumor cells in vitro and in vivo by gene therapy with INF-beta gene in recombinant baculovirus vector/O. Lykhova [et al.] // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.90
|
|
|